C. McAleer

Phase II study of topotecan in metastatic hormone-refractory prostate cancer

R. Ozols, G. Hudes, R. Greenberg, 2004, Investigational New Drugs.

Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5.

J. Wright, R. Schilder, S. Kaul, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma

I. Astsaturov, M. Hall, R. Alpaugh, 2016, Pancreas.

Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule.

R. Perez, S. Johnson, T. Hamilton, 1994, Cancer research.

Phase I and Pharmacokinetic Study of the Cytotoxic Ether Lipid Ilmofosine Administered by Weekly Two-Hour Infusion in Patients with Advanced Solid Tumors

P. O'dwyer, B. Giantonio, J. Mcphillips, 2004, Clinical Cancer Research.

Phase I trial of ilmofosine as a 24 hour infusion weekly

M. Mehren, P. O'dwyer, R. Schilder, 2004, Investigational New Drugs.

Characteristics of female smokers attending a lung cancer screening program: a pilot study with implications for program development.

Suzanne M. Miller, T. Halbherr, R. Schnoll, 2002, Lung cancer.